Artelo Biosciences Inc. (ARTLW)
NASDAQ: ARTLW
· Real-Time Price · USD
0.01
0.00 (78.57%)
At close: Jun 17, 2024, 10:00 PM
Artelo Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
Net Income | -9.44M | -10.29M | -10.08M | -9.29M | -8.85M | -8.65M | -8.55M | -7.44M | -6.58M | -5.28M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 61.00 | 123.00 | 183.00 | 311.00 | 374.00 |
Stock-Based Compensation | 1.79M | 2.19M | 2.46M | 2.42M | 2.33M | 2.33M | 2.05M | 1.53M | 1.06M | 497.17K |
Other Working Capital | 236K | 331K | -195K | -271K | -410K | -824.55K | -204.85K | -42.65K | 60.33K | 88.41K |
Other Non-Cash Items | -518K | -354K | -211K | -75K | 1.82K | 26.15K | 5.82K | 6.82K | n/a | -1.33K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 362K | 311K | -172K | -695K | -973.32K | -1.01M | -254.17K | -242K | 42.29K | 70.37K |
Operating Cash Flow | -7.8M | -8.14M | -8.01M | -7.64M | -7.49M | -7.3M | -6.75M | -6.14M | -5.47M | -4.71M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.18K | 1.18K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -18.19M | -16.58M | -13.22M | -21.8M | -13.94M | -13.2M | -10.76M | n/a | n/a | n/a |
Sales Maturities Of Investments | 19.51M | 21.48M | 16.18M | 14.08M | 9.31M | 4.58M | 1.88M | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -3.44M | -2.93M | -2.93M | -2.93M | 510.69K | n/a |
Investing Cash Flow | 1.31M | 4.9M | 2.96M | -7.72M | -8.07M | -11.55M | -12.32M | -3.44M | 1.18K | -509.52K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.00 | 9.00 |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | 1.11M | 1.7M | 7.02M | 6.01M | 5.01M | 4.32M |
Financial Cash Flow | -1.12M | n/a | n/a | 18.13M | 19.72M | 20.48M | 25.8M | 14.11M | 14.23M | 13.89M |
Net Cash Flow | -6.4M | -3.43M | -5.27M | 2.39M | 3.95M | 1.53M | 6.66M | 4.49M | 8.77M | 8.72M |
Free Cash Flow | -7.8M | -8.14M | -8.01M | -7.64M | -7.49M | -7.3M | -6.75M | -6.14M | -5.47M | -4.71M |